PortfoliosLab logoPortfoliosLab logo
The Chemours Company (CC)
Performance
Return for Risk
Dividends
Drawdowns
Volatility
Financials

Company Info

ISIN
US1638511089
IPO Date
Jul 1, 2015

Highlights

Market Cap
$3.32B
Enterprise Value
$2.93B
EPS (TTM)
-$2.47
Total Revenue (TTM)
$4.48B
Gross Profit (TTM)
$749.00M
EBITDA (TTM)
$504.00M
Year Range
$9.13 - $22.43
Target Price
$19.60
ROA (TTM)
-5.04%
ROE (TTM)
-148.80%

Share Price Chart


Loading graphics...

Compare stocks, funds, or ETFs

Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.


The Chemours Company

Performance

Performance Chart

The chart shows the growth of an initial investment of $10,000 in The Chemours Company, comparing it to the performance of the S&P 500 index or another benchmark. All prices have been adjusted for splits and dividends.


Loading graphics...

S&P 500 Index

Returns By Period

The Chemours Company (CC) has returned 87.80% so far this year and 67.11% over the past 12 months. Looking at the last ten years, CC has achieved an annualized return of 15.13%, outperforming the S&P 500 Index benchmark, which averaged 12.16% per year.


The Chemours Company

1D
3.92%
1M
20.78%
YTD
87.80%
6M
40.79%
1Y
67.11%
3Y*
-6.26%
5Y*
-1.47%
10Y*
15.13%

Benchmark (S&P 500 Index)

1D
2.91%
1M
-5.09%
YTD
-4.63%
6M
-2.39%
1Y
16.33%
3Y*
16.69%
5Y*
10.18%
10Y*
12.16%
*Multi-year figures are annualized to reflect compound growth (CAGR)

Monthly Returns

Based on dividend-adjusted daily data since Jul 1, 2015, CC's average daily return is +0.10%, while the average monthly return is +2.03%. At this rate, your investment would double in approximately 2.9 years.

Historically, 52% of months were positive and 48% were negative. The best month was Nov 2016 with a return of +50.7%, while the worst month was May 2019 at -40.8%. The longest winning streak lasted 6 consecutive months, and the longest losing streak was 5 months.

On a daily basis, CC closed higher 49% of trading days. The best single day was Dec 18, 2015 with a return of +26.3%, while the worst single day was Feb 29, 2024 at -31.5%.


JanFebMarAprMayJunJulAugSepOctNovDecTotal
202627.14%22.30%20.78%87.80%
202512.37%-19.96%-9.50%-8.50%-17.52%13.03%4.63%29.30%2.86%-15.47%-3.79%-7.82%-27.57%
2024-4.34%-34.25%33.50%1.87%-6.40%-9.07%7.09%-18.45%4.53%-10.63%21.28%-22.26%-44.01%
202318.84%-5.37%-12.40%-2.91%-8.06%39.26%0.24%-7.33%-17.55%-14.05%14.92%14.98%6.53%
2022-2.53%-14.87%14.06%5.05%31.16%-25.69%11.15%-4.56%-26.92%16.15%9.26%-1.38%-5.99%
20216.25%-9.77%18.61%8.20%19.86%-3.15%-4.45%1.52%-13.28%-3.58%6.82%13.00%39.85%

Benchmark Metrics

The Chemours Company has an annualized alpha of 4.01%, beta of 1.72, and R² of 0.25 versus S&P 500 Index. Calculated based on daily prices since July 02, 2015.

  • This stock participated in 167.87% of S&P 500 Index downside but only 165.25% of its upside — more exposed to losses than it benefited from rallies.
  • R² of 0.25 means this stock moves largely independently of S&P 500 Index — capture ratios reflect limited market correlation rather than active downside protection. Consider using a more representative benchmark.

Alpha
4.01%
Beta
1.72
0.25
Upside Capture
165.25%
Downside Capture
167.87%

Return for Risk

Risk / Return Rank

CC ranks 71 for risk / return — better than 71% of stocks on our site. You're getting solid returns for the risk taken. A good sign, especially for investors who want growth without excessive volatility.


CC Risk / Return Rank: 7171
Overall Rank
CC Sharpe Ratio Rank: 7373
Sharpe Ratio Rank
CC Sortino Ratio Rank: 7171
Sortino Ratio Rank
CC Omega Ratio Rank: 6868
Omega Ratio Rank
CC Calmar Ratio Rank: 7272
Calmar Ratio Rank
CC Martin Ratio Rank: 7070
Martin Ratio Rank
The rank (0–100) shows how this investment's returns compare to the risk taken. Higher = better. Based on the past 12 months of data, combining Sharpe, Sortino, and other metrics used by quantitative funds and institutional investors.

Return / Risk — by metrics

The table below present risk-adjusted performance metrics for The Chemours Company (CC) and compare them to a chosen benchmark (S&P 500 Index).


CCBenchmarkDifference

Sharpe ratio

Return per unit of total volatility

0.97

0.90

+0.07

Sortino ratio

Return per unit of downside risk

1.68

1.39

+0.30

Omega ratio

Gain probability vs. loss probability

1.21

1.21

0.00

Calmar ratio

Return relative to maximum drawdown

1.63

1.40

+0.23

Martin ratio

Return relative to average drawdown

3.59

6.61

-3.02

Explore CC risk-adjusted metrics in detail

Dive deeper into individual metrics with historical trends, benchmark comparisons, and performance across different time periods.

Dividends

Dividend History

The Chemours Company provided a 1.59% dividend yield over the last twelve months, with an annual payout of $0.35 per share.


0.00%2.00%4.00%6.00%8.00%10.00%$0.00$0.20$0.40$0.60$0.80$1.0020152016201720182019202020212022202320242025
Dividends
Dividend Yield
PeriodTTM20252024202320222021202020192018201720162015
Dividend$0.35$0.51$1.00$1.00$1.00$1.00$1.00$1.00$0.84$0.12$0.12$0.58

Dividend yield

1.59%4.35%5.92%3.17%3.27%2.98%4.03%5.53%2.98%0.24%0.54%10.82%

Monthly Dividends

The table displays the monthly dividend distributions for The Chemours Company. The dividends shown in the table have been adjusted to account for any splits that may have occurred.


JanFebMarAprMayJunJulAugSepOctNovDecTotal
2026$0.00$0.09$0.00$0.09
2025$0.00$0.25$0.00$0.00$0.09$0.00$0.00$0.09$0.00$0.00$0.09$0.00$0.51
2024$0.00$0.25$0.00$0.00$0.25$0.00$0.00$0.25$0.00$0.00$0.25$0.00$1.00
2023$0.00$0.25$0.00$0.00$0.25$0.00$0.00$0.25$0.00$0.00$0.25$0.00$1.00
2022$0.00$0.25$0.00$0.00$0.25$0.00$0.00$0.25$0.00$0.00$0.25$0.00$1.00
2021$0.00$0.25$0.00$0.00$0.25$0.00$0.00$0.25$0.00$0.00$0.25$0.00$1.00

Drawdowns

Drawdowns Chart

The Drawdowns chart displays portfolio losses from any high point along the way. Drawdowns are calculated considering price movements and all distributions paid, if any.


Loading graphics...

Worst Drawdowns

The table below displays the maximum drawdowns of the The Chemours Company. A maximum drawdown is a measure of risk, indicating the largest reduction in portfolio value due to a series of losing trades.

The maximum drawdown for the The Chemours Company was 86.15%, occurring on Apr 3, 2020. The portfolio has not yet recovered.

The current The Chemours Company drawdown is 47.21%.


Depth

Start

To Bottom

Bottom

To Recover

End

Total

-86.15%Oct 30, 2017611Apr 3, 2020
-80.12%Jul 6, 2015143Jan 27, 2016172Sep 30, 2016315
-22.68%May 17, 201729Jun 27, 201718Jul 24, 201747
-21.29%Dec 9, 201616Jan 3, 201722Feb 3, 201738
-10.77%Aug 8, 20173Aug 10, 201716Sep 1, 201719

Volatility

Volatility Chart

The chart below shows the rolling one-month volatility.


Loading graphics...

Financials

Financial Performance

The chart below illustrates the trends in the financial health of The Chemours Company over time, highlighting three key metrics: Total Revenue, Earnings Before Interest and Taxes (EBIT), and Net Income.


Annual
Quarterly

0.0

Valuation

The Valuation section provides an overview of how The Chemours Company is priced in the market compared to other companies in the Specialty Chemicals industry. It includes key financial ratios that help investors assess whether the stock is undervalued or overvalued.


PS Ratio

This chart shows the Price-to-Sales (P/S) ratio for CC relative to other companies in the Specialty Chemicals industry. Currently, CC has a P/S ratio of 0.7. This P/S ratio falls within the average range for the industry, suggesting the stock is fairly valued based on its revenue.

PB Ratio

The chart illustrates the Price-to-Book (P/B) ratio for CC in comparison with other companies in the Specialty Chemicals industry. Currently, CC has a P/B value of 13.3. This P/B ratio is higher than most companies in the industry. It may suggest the stock is overvalued or that investors expect the company to generate high returns on its assets.

Income Statement



TTM
Revenue

Total Revenue

Cost Of Revenue

Gross Profit

Operating Expenses

Selling, General & Admin Expenses

R&D Expenses

Depreciation And Amortization

Total Operating Expenses

Income

Income Before Tax

Operating Income

EBITDA

EBIT

Earnings From Continuing Operations

Net Income

Income Tax Expense

Other Non-Operating Income (Expenses)

Extraordinary Items

Discontinued Operations

Effect Of Accounting Charges

Non Recurring

Minority Interest

Other Items

Interest Income

Interest Expense

Net Interest Income

Values in undefined except per share items